Great Ormond Street Hospital Clinical Trial Co-ordinator
Manju AgarwalAs part of the Newcastle Plan in 2015/16, eight patient organisations contributed £1.2m to fund at least 16 vital posts across the UK to support and expand clinical trial capacity for Duchenne muscular dystrophy. One of those posts was a new clinical trial co-ordinator role at Great Ormond Street Hospital, which the Duchenne Research Fund, Duchenne UK and Harrison’s Fund co-funded together with Great Ormond Street Hospital Children’s Charity. Ms Manju Agarwal was subsequently recruited to fill the role. The initiative evolved into the DMD Hub, spearheaded by Duchenne UK and supported by the other charities, which aims to respond to clinical trial capacity needs across the UK. The objective of the Hub is to enable all patients to have access to clinical trials.
Clinical support post
£30,000 contribution
Funded in 2017-20
London, UK
Latest research news
Duchenne Care UK podcast series launched
On World Duchenne Awareness Day 2026, we are pleased to share the launch of the Duchenne Care UK podcast series. The series is based on the Duchenne Care UK Patient and Family Guides and break down information into accessible, short episodes …
Duchenne Care UK orthopaedic guideline recognised by NICE
We are pleased to share that NICE has recognised a third set of guidelines – the orthopaedic care guidelines that were created and published by the Duchenne Care UK programme that we fund …
Landmark day for Duchenne as Givinostat approved for use in England
On a landmark day for the Duchenne muscular dystrophy community, we are delighted to share that the National Institute for Health and Care Excellence (NICE) has recommended the treatment givinostat (brand name Duvyzat) for use on the NHS in England. In final draft...
Our projects
Learn more about what we fund.
Latest news
Catch up on our fundraising and research progress.